B
Bailard Portfolio holdings
AUM
$4.29B
1-Year Return
18.39%
This Quarter Return
+21.06%
1 Year Return
+18.39%
3 Year Return
+76.25%
5 Year Return
+133.74%
10 Year Return
+353.73%
AUM
$1.79B
AUM Growth
+$386M
(+27%)
Cap. Flow
+$127M
Cap. Flow
% of AUM
7.07%
Top 10 Holdings %
Top 10 Hldgs %
33.84%
Holding
575
New
129
Increased
174
Reduced
152
Closed
75
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$49.8M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
$41.8M |
| 3 |
iShares National Muni Bond ETF
MUB
|
$10.7M |
| 4 |
Vanguard Small-Cap Value ETF
VBR
|
$4.45M |
| 5 |
L3Harris
LHX
|
$4.12M |
Top Sells
| 1 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
$5.76M |
| 2 |
SPDR Nuveen ICE Municipal Bond ETF
TFI
|
$4.69M |
| 3 |
Gilead Sciences
GILD
|
$4.57M |
| 4 |
Meta Platforms (Facebook)
META
|
$4.47M |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
$4.41M |
Sector Composition
| 1 | Technology | 16.8% |
| 2 | Healthcare | 8.12% |
| 3 | Financials | 4.94% |
| 4 | Communication Services | 4.63% |
| 5 | Consumer Discretionary | 4.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Sanofi
SNY
$113B
| $598K | 0.03% |
11,717
+1,188
| +11% | +$60.6K |
|
252
Vanguard Small-Cap ETF
VB
$67.2B
| $597K | 0.03% |
4,100
-1,377
| -25% | -$201K |
|
253
Vanguard Materials ETF
VAW
$2.89B
| $596K | 0.03% |
4,938
-1,327
| -21% | -$160K |
|
254
Applied Materials
AMAT
$130B
| $592K | 0.03% |
9,797
-257
| -3% | -$15.5K |
|
255
Enbridge
ENB
$105B
| $588K | 0.03% |
19,339
+899
| +5% | +$27.3K |
|
|
AIV
256
Aimco
AIV
$1.11B
| $568K | 0.03% |
+113,353
| New | +$568K |
|
257
Air Products & Chemicals
APD
$64.5B
| $564K | 0.03% |
2,334
+72
| +3% | +$17.4K |
|
258
Apellis Pharmaceuticals
APLS
$3.55B
| $552K | 0.03% |
16,900
+5,000
| +42% | +$163K |
|
259
RTX Corp
RTX
$211B
| $549K | 0.03% |
8,903
-7,669
| -46% | -$473K |
|
260
SPDR S&P 600 Small Cap Value ETF
SLYV
$4.09B
| $545K | 0.03% |
11,092
-629
| -5% | -$30.9K |
|
|
FBC
261
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $542K | 0.03% |
18,400
+4,900
| +36% | +$144K |
|
262
Associated Banc-Corp
ASB
$4.42B
| $536K | 0.03% |
+39,200
| New | +$536K |
|
263
FibroGen
FGEN
$48.9M
| $533K | 0.03% |
526
| – | – |
|
264
Alexandria Real Estate Equities
ARE
$14.5B
| $530K | 0.03% |
3,265
+105
| +3% | +$17K |
|
265
iShares Biotechnology ETF
IBB
$5.8B
| $530K | 0.03% |
3,880
| – | – |
|
266
COPT Defense Properties
CDP
$3.46B
| $527K | 0.03% |
20,800
+9,500
| +84% | +$241K |
|
267
Alnylam Pharmaceuticals
ALNY
$59.4B
| $518K | 0.03% |
3,500
| – | – |
|
268
The Bancorp
TBBK
$3.49B
| $510K | 0.03% |
52,000
+6,100
| +13% | +$59.8K |
|
269
Becton Dickinson
BDX
$55.1B
| $506K | 0.03% |
2,169
-786
| -27% | -$183K |
|
270
Iovance Biotherapeutics
IOVA
$901M
| $505K | 0.03% |
18,400
-48,200
| -72% | -$1.32M |
|
271
BioMarin Pharmaceuticals
BMRN
$11.1B
| $493K | 0.03% |
4,000
| – | – |
|
272
Fresenius Medical Care
FMS
$14.5B
| $490K | 0.03% |
11,320
+422
| +4% | +$18.3K |
|
|
RC
273
Ready Capital
RC
$705M
| $484K | 0.03% |
55,746
+2,607
| +5% | +$22.6K |
|
274
Biogen
BIIB
$20.6B
| $478K | 0.03% |
1,788
+27
| +2% | +$7.22K |
|
275
Digital Realty Trust
DLR
$55.7B
| $478K | 0.03% |
3,367
| – | – |
|